(Q31110980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

review article

1 reference

title

Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

1 reference

1 reference

systolic heart failure

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

author name string

Anjan Deka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Burhan Mohamedali

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Gary L Schaer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

1 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

1911-1923

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27349212%20AND%20SRC:MED&resulttype=core&format=json

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

16 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-control

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Stem cell therapy for heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087

Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: A prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368916X692087